nach oben

Reactions Weekly

Erschienen in:

01.09.2021 | Case report

Ribavirin/sofosbuvir/sofosbuvir/velpatasvir

Failure to achieve sustained virological response in hepatitis-C: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Tang Q, et al. Sofosbuvir-based therapies achieved satisfactory virological response in Chinese individuals with genotypes 3 and 6 infections: A real-world experience. Infection and Drug Resistance 14: 2297-2307, 21 Jun 2021. Available from: URL: https://www.dovepress.com/getfile.php?fileID=70764

Titel: Ribavirin/sofosbuvir/sofosbuvir/velpatasvir
Failure to achieve sustained virological response in hepatitis-C: 5 case reports
Publikationsdatum: 01.09.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-01886-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Dexamethasone

Secukinumab

Dimethyl-fumarate/methylprednisolone

Antiepileptic-drugs

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis

Cyclophosphamide/methylprednisolone/prednisolone